Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 4Phase NA 3Phase 1/2 3Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 373Lymphoid 180Other hematologic neoplasm 109Gastrointestinal 18Thoracic 16Genitourinary 16Breast 11CNS 8Head & Neck 7Myeloid 6Tumor-Agnostic 5Dermatologic 5Sarcoma 4Gynecologic 4Other solid neoplasm 2Other 2Classical hematology 2Endocrine 1

Conditions

Ovarian Neoplasms 2Neoplasms 2Endometrial Neoplasms 2Uterine Neoplasms 1Ovarian Diseases 1Neoplasms by Site 1Genital Diseases, Female 1Endocrine Gland Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Adnexal Diseases 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 134pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Letrozole 28Drug Therapy 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23durvalumab 22Albumin-Bound Paclitaxel 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20Specimen Handling 20Filgrastim 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Dexamethasone × Gynecologic × Clear all
NCT00515073 2014-07-03

Papillary Serous Carcinoma of the Endometrium

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled 5 charts
Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT00003449 2014-05-22

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

University of Southern California

Phase 2 Completed
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00050414 2013-01-10

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
147 enrolled
Gynecologic

Adnexal Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms

NCT00050440 2013-01-08

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
50 enrolled
Gynecologic

Carcinoma, Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡